Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.
2.

Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial.

Fujioka T, Arakawa T, Shimoyama T, Yoshikawa T, Itoh M, Asaka M, Ishii H, Kuwayama H, Sato R, Kawai S, Takemoto T, Kobayashi K.

Aliment Pharmacol Ther. 2003 Jul;18 Suppl 1:146-52.

3.

Anti-inflammatory effects of rebamipide according to Helicobacter pylori status in patients with chronic erosive gastritis: a randomized sucralfate-controlled multicenter trial in China-STARS study.

Du Y, Li Z, Zhan X, Chen J, Gao J, Gong Y, Ren J, He L, Zhang Z, Guo X, Wu J, Tian Z, Shi R, Jiang B, Fang D, Li Y.

Dig Dis Sci. 2008 Nov;53(11):2886-95. doi: 10.1007/s10620-007-0180-z. Epub 2008 Feb 21.

PMID:
18288617
4.

Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice.

Hahm KB, Kim DH, Lee KM, Lee JS, Surh YJ, Kim YB, Yoo BM, Kim JH, Joo HJ, Cho YK, Nam KT, Cho SW.

Aliment Pharmacol Ther. 2003 Jul;18 Suppl 1:24-38.

5.

Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.

Terano A, Arakawa T, Sugiyama T, Suzuki H, Joh T, Yoshikawa T, Higuchi K, Haruma K, Murakami K, Kobayashi K; Rebamipide Clinical Study Group..

J Gastroenterol. 2007 Aug;42(8):690-3. Epub 2007 Aug 24.

PMID:
17701133
6.

Comparison of the effects of rebamipide with those of cimetidine on chronic gastritis associated with Helicobacter pylori in Mongolian gerbils.

Higuchi K, Tanigawa T, Hamaguchi M, Takashima T, Sasaki E, Shiba M, Tominaga K, Fujiwara Y, Oshitani N, Matsumoto T, Watanabe T, Arakawa T.

Aliment Pharmacol Ther. 2003 Jul;18 Suppl 1:1-7.

7.

A short-term eradication therapy for Helicobacter pylori acute gastritis.

Nomura H, Miyake K, Kashiwagi S, Sugiyama T, Asaka M.

J Gastroenterol Hepatol. 2000 Dec;15(12):1377-81.

PMID:
11197046
8.

Rebamipide: a gastrointestinal protective drug with pleiotropic activities.

Naito Y, Yoshikawa T.

Expert Rev Gastroenterol Hepatol. 2010 Jun;4(3):261-70. doi: 10.1586/egh.10.25.

PMID:
20528113
9.

Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status.

Higuchi K, Arakawa T, Nebiki H, Uchida T, Fujiwara Y, Ando K, Yamasaki K, Takaishi O, Fukuda T, Kobayashi K, Kuroki T.

Dig Dis Sci. 1998 Sep;43(9 Suppl):99S-106S.

PMID:
9753234
10.

Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy: a systematic review and meta-analysis.

Nishizawa T, Nishizawa Y, Yahagi N, Kanai T, Takahashi M, Suzuki H.

J Gastroenterol Hepatol. 2014 Dec;29 Suppl 4:20-4. doi: 10.1111/jgh.12769.

PMID:
25521728
11.

Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis.

Haruma K, Ito M, Kido S, Manabe N, Kitadai Y, Sumii M, Tanaka S, Yoshihara M, Chayama K.

Dig Dis Sci. 2002 Apr;47(4):862-7.

PMID:
11991622
12.

Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing.

Arakawa T, Kobayashi K, Yoshikawa T, Tarnawski A.

Dig Dis Sci. 1998 Sep;43(9 Suppl):5S-13S. Review.

PMID:
9753220
13.
14.

Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils.

Watanabe T, Higuchi K, Hamaguchi M, Tanigawa T, Wada R, Tominaga K, Fujiwara Y, Arakawa T.

Dig Dis Sci. 2002 Jul;47(7):1582-9.

PMID:
12141820
15.

An open-labeled study of rebamipide treatment in chronic gastritis patients with dyspeptic symptoms refractory to proton pump inhibitors.

Chitapanarux T, Praisontarangkul OA, Lertprasertsuke N.

Dig Dis Sci. 2008 Nov;53(11):2896-903. doi: 10.1007/s10620-008-0255-5. Epub 2008 May 2.

PMID:
18452057
16.

Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study.

Han X, Jiang K, Wang B, Zhou L, Chen X, Li S.

Clin Drug Investig. 2015 Oct;35(10):665-73. doi: 10.1007/s40261-015-0329-z.

PMID:
26369655
17.

Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.

Kato M, Asaka M, Sugiyama T, Kudo M, Nishikawa K, Sukegawa M, Hokari K, Katagiri M, Sato F, Kagaya H, Takeda H.

Dig Dis Sci. 1998 Sep;43(9 Suppl):198S-202S.

PMID:
9753250
18.

Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide.

Hahm KB, Lee KJ, Kim YS, Kim JH, Cho SW, Yim H, Joo HJ.

Dig Dis Sci. 1998 Feb;43(2):235-40.

PMID:
9512112
19.

Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer.

Nebiki H, Higuchi K, Arakawa T, Ando K, Uchida T, Ito H, Harihara S, Kuroki T, Kobayashi K.

Dig Dis Sci. 1998 Sep;43(9 Suppl):203S-206S.

PMID:
9753251
20.

[Rebamipide].

Shimoyama T, Fukuda S, Liu Q, Sugawara K.

Nihon Rinsho. 2002 Feb;60 Suppl 2:698-703. Review. Japanese. No abstract available.

PMID:
11979874

Supplemental Content

Support Center